Published in Clin Exp Nephrol on September 01, 2005
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A (2009) 3.13
Physiology, structure, and regulation of the cloned organic anion transporters. Xenobiotica (2008) 1.40
Developments in the scientific and clinical understanding of gout. Arthritis Res Ther (2008) 1.26
A role for xanthine oxidase in the control of fetal cardiovascular function in late gestation sheep. J Physiol (2012) 1.06
Gout, diuretics and the kidney. Ann Rheum Dis (2006) 1.02
Renal organic anion transporters (SLC22 family): expression, regulation, roles in toxicity, and impact on injury and disease. AAPS J (2012) 0.98
Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies. Clin Exp Nephrol (2011) 0.98
Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol (2014) 0.96
Effects of basal level of antioxidants on oxidative DNA damage in humans. Eur J Nutr (2007) 0.87
Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress. Ann Indian Acad Neurol (2014) 0.81
Metabolic Interactions of Purine Derivatives with Human ABC Transporter ABCG2: Genetic Testing to Assess Gout Risk. Pharmaceuticals (Basel) (2013) 0.81
Immunohistochemical studies of organic anion transporters and urate transporter 1 expression in human salivary gland. Acta Odontol Scand (2012) 0.80
[New knowledge on the pathophysiology and therapy of gout]. Z Rheumatol (2007) 0.79
[Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1]. Z Rheumatol (2007) 0.79
Short-term regulation of organic anion transporters. Pharmacol Ther (2009) 0.78
Quantitative estimation of urate transport in nephrons in relation to urinary excretion employing benzbromarone-loading urate clearance tests in cases of hyperuricemia. Nephron Extra (2011) 0.78
Gout: An old disease in new perspective - A review. J Adv Res (2017) 0.78
Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1. Evid Based Complement Alternat Med (2012) 0.77
Effects of Increased Uric Acid Intake on the Abundance of Urate-anion exchanger and Organic Anion Transporter Proteins in the Rat Kidney. Electrolyte Blood Press (2007) 0.77
[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency]. Z Rheumatol (2015) 0.77
Urate Handling in the Human Body. Curr Rheumatol Rep (2016) 0.76
A case of renal hypouricemia and a G774A gene mutation causing acute renal injury that was improved by hemodialysis. CEN Case Rep (2012) 0.75
Epigenetic profiles of pre-diabetes transitioning to type 2 diabetes and nephropathy. World J Diabetes (2015) 0.75
Effect of probenecid on pharmacokinetics and tolerability of olmesartan in healthy chinese volunteers. Curr Ther Res Clin Exp (2014) 0.75
Total saponins from Discorea nipponica makino ameliorate urate excretion in hyperuricemic rats. Pharmacogn Mag (2015) 0.75
Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model. BMC Complement Altern Med (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Molecular identification of a danger signal that alerts the immune system to dying cells. Nature (2003) 8.90
Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet (2004) 5.83
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension (2003) 5.47
An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet (2003) 4.61
A role for uric acid in the progression of renal disease. J Am Soc Nephrol (2002) 3.77
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch (2003) 3.76
PDZ domains: structural modules for protein complex assembly. J Biol Chem (2001) 3.59
Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol (1992) 2.35
Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A (1998) 2.21
The renal mechanism for urate excretion in man. J Clin Invest (1950) 2.19
Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell (2000) 2.15
Regulation of renal urate excretion: a critical review. Am J Kidney Dis (1998) 2.00
The SLC22 drug transporter family. Pflugers Arch (2003) 1.95
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med (1994) 1.87
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol (2004) 1.87
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem (2002) 1.87
Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A (1989) 1.85
Expression cloning and characterization of ROAT1. The basolateral organic anion transporter in rat kidney. J Biol Chem (1997) 1.75
Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol (2003) 1.69
PDZK1: I. a major scaffolder in brush borders of proximal tubular cells. Kidney Int (2003) 1.64
Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem (1997) 1.62
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet (1999) 1.61
Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem (2000) 1.60
Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Invest (1998) 1.52
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci (2004) 1.52
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem (1999) 1.48
The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl (1997) 1.43
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol (2001) 1.41
The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem (2004) 1.40
Studies of hyperuricemia produced by pyrazinamide. Am J Med (1957) 1.38
Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol (2002) 1.32
Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys. Kidney Int Suppl (1997) 1.30
Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A (2002) 1.22
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett (1998) 1.19
Regulation of mOAT-mediated organic anion transport by okadaic acid and protein kinase C in LLC-PK(1) cells. J Biol Chem (2000) 1.14
Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem (2003) 1.14
The multispecific organic anion transporter (OAT) family. Pflugers Arch (2000) 1.14
The organic anion transporter family: from physiology to ontogeny and the clinic. Am J Physiol Renal Physiol (2001) 1.13
Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int (2004) 1.11
Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol (2004) 1.11
Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol (1999) 1.10
Action of biologically-relevant oxidizing species upon uric acid. Identification of uric acid oxidation products. Chem Biol Interact (1990) 1.07
Acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise in patients with or without renal hypouricemia. Nephron (2002) 1.06
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther (2002) 1.05
Comparison of uric acid and ascorbic acid in protection against EAE. Free Radic Biol Med (2002) 1.05
Antioxidants and aging. Am J Clin Nutr (1991) 1.04
Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects. Eur J Clin Pharmacol (1992) 0.99
Oxidation of urate in human skeletal muscle during exercise. Free Radic Biol Med (1997) 0.98
Cause of persistent hypouricemia in outpatients. Nephron (1989) 0.98
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem (2002) 0.97
Kidney function: gateway to a long life? Nature (2002) 0.93
Uric acid nephrolithiasis. Miner Electrolyte Metab (1994) 0.93
Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update (1997) 0.93
Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction. Clin Nephrol (2000) 0.93
Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int (2003) 0.91
Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens (2003) 0.91
Cloning of a human renal p-aminohippurate transporter, hROAT1. Kidney Blood Press Res (1998) 0.90
The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol (2004) 0.90
Inactivation of alpha 1-antiproteinase by hydroxyl radicals. The effect of uric acid. FEBS Lett (1989) 0.89
Exercise-induced acute renal failure in 3 patients with renal hypouricemia. Nihon Jinzo Gakkai Shi (1990) 0.88
Renal hypouricemia: prevention of exercise-induced acute renal failure and a review of the literature. Am J Kidney Dis (1995) 0.86
The molecular biology of renal organic anion and organic cation transporters. Cell Biochem Biophys (1999) 0.85
Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J Clin Invest (2001) 0.83
Recurrence of acute renal failure and renal hypouricaemia. Pediatr Nephrol (1993) 0.83
Hypouricemia due to an increment in renal tubular urate secretion. Arch Intern Med (1982) 0.83
Acute renal failure after exercise in a child with renal hypouricaemia. Pediatr Nephrol (1993) 0.82
Urate transport in brush-border membrane of human kidney. Am J Physiol (1994) 0.79
Urate secretion in man: the pyrazinamide suppression test. Ann Intern Med (1973) 0.79
Renal hypouricemia due to an isolated renal defect of urate transport. Nephron (1988) 0.75
Modulation of the basolateral and apical step of transepithelial organic anion secretion in proximal tubular opossum kidney cells. Acute effects of epidermal growth factor and mitogen-activated protein kinase. J Biol Chem (2001) 0.75
Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature (2002) 5.62
CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch (2003) 2.69
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09
New insights into renal transport of urate. Curr Opin Rheumatol (2007) 2.07
The SLC22 drug transporter family. Pflugers Arch (2003) 1.95
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol (2004) 1.87
Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol (2006) 1.83
Molecular physiology of urate transport. Physiology (Bethesda) (2005) 1.69
Transport of 99mTc-MAG3 via rat renal organic anion transporter 1. J Nucl Med (2004) 1.66
L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer (2006) 1.57
L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer. Pathol Int (2009) 1.57
Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci (2004) 1.52
Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol (2006) 1.44
Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol Pharmacol (2002) 1.44
Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition. Am J Physiol Renal Physiol (2004) 1.43
A novel role of the C-terminus of b 0,+ AT in the ER-Golgi trafficking of the rBAT-b 0,+ AT heterodimeric amino acid transporter. Biochem J (2009) 1.41
The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem (2004) 1.40
l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci (2008) 1.37
Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem (2003) 1.34
Organic anion transporter family: current knowledge. J Pharmacol Sci (2006) 1.34
Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol (2005) 1.33
Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol (2002) 1.32
Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther (2002) 1.31
Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther (2003) 1.25
A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int (2004) 1.24
High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: comparison with non-cancerous lesions. Pathol Int (2011) 1.22
Mutational and functional analysis of SLC4A4 in a patient with proximal renal tubular acidosis. Pflugers Arch (2004) 1.19
Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout. Ann Rheum Dis (2009) 1.16
Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest (2006) 1.15
Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol (2002) 1.14
L-type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci (2009) 1.13
Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int (2004) 1.11
Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol (2004) 1.11
Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells. Biochim Biophys Acta (2002) 1.10
Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J Pharmacol Exp Ther (2002) 1.10
Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology (2007) 1.09
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem (2010) 1.09
Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem Biophys Res Commun (2004) 1.09
Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study. Clin Cancer Res (2007) 1.07
The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics (2002) 1.07
LAT1 is a critical transporter of essential amino acids for immune reactions in activated human T cells. J Immunol (2013) 1.07
Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther (2002) 1.05
Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract. Virchows Arch (2007) 1.05
Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int (2004) 1.04
Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol (2005) 1.03
Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J Pharmacol Exp Ther (2005) 1.02
Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. J Nucl Med (2012) 1.02
Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J Toxicol Sci (2003) 1.01
Altered expression of rat renal cortical OAT1 and OAT3 in response to bilateral ureteral obstruction. Kidney Int (2005) 1.01
The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci (2004) 1.01
BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol Pharm Bull (2008) 1.00
The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells. Anticancer Res (2006) 1.00
A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum (2005) 1.00
Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther (2002) 0.99
A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters. J Pharmacol Exp Ther (2005) 0.99
Sodium-hydrogen exchanger regulatory factor-1 interacts with mouse urate transporter 1 to regulate renal proximal tubule uric acid transport. J Am Soc Nephrol (2007) 0.98
Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther (2002) 0.98
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. J Pharmacol Exp Ther (2002) 0.98
Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer. Cancer Sci (2009) 0.98
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97
Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J Pharmacol Exp Ther (2002) 0.97
Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem (2002) 0.97
Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule. Arch Pharm Res (2005) 0.97
Localization of Na+-HCO-3 cotransporter (NBC-1) variants in rat and human pancreas. Am J Physiol Cell Physiol (2002) 0.97
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab (2005) 0.97
Cadmium transport by human Nramp 2 expressed in Xenopus laevis oocytes. Toxicol Appl Pharmacol (2003) 0.96
Association between GLUT9 and gout in Japanese men. Ann Rheum Dis (2010) 0.96
L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Histopathology (2009) 0.96
Identification of a novel Na+-independent acidic amino acid transporter with structural similarity to the member of a heterodimeric amino acid transporter family associated with unknown heavy chains. J Biol Chem (2002) 0.96
Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep (2005) 0.95
Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens (2005) 0.95
Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Lab Invest (2011) 0.94
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol (2003) 0.94
Protein characterization of NA+-independent system L amino acid transporter 3 in mice: a potential role in supply of branched-chain amino acids under nutrient starvation. Am J Pathol (2007) 0.94
Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem (2003) 0.94
Roles of organic anion transporters in the renal excretion of perfluorooctanoic acid. Basic Clin Pharmacol Toxicol (2008) 0.93
Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters. J Pharmacol Sci (2008) 0.93
System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci Res (2004) 0.93
Interactions of urate transporter URAT1 in human kidney with uricosuric drugs. Nephrology (Carlton) (2011) 0.93
Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology (2007) 0.93
LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Virchows Arch (2005) 0.92
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol (2002) 0.92
Expression of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (4F2hc) in oral squamous cell carcinoma and its precusor lesions. Anticancer Res (2004) 0.92
Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors. Eur J Pharmacol (2004) 0.92
Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int (2003) 0.91
Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Pathol Res Pract (2008) 0.91
Human organic anion transporters mediate the transport of tetracycline. Jpn J Pharmacol (2002) 0.90
High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J Clin Pathol (2012) 0.90
Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci (2003) 0.90
Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstruction. Hepatology (2006) 0.90
The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr Nephrol (2004) 0.90
Urate transporters: an evolving field. Semin Nephrol (2011) 0.90
Nephrin and podocin expression around the onset of puromycin aminonucleoside nephrosis. J Pharmacol Sci (2005) 0.89
Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. J Pharmacol Exp Ther (2003) 0.89
Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine. J Pharmacol Sci (2004) 0.89
Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med (2010) 0.89
Isolation, characterization and differential gene expression of multispecific organic anion transporter 2 in mice. Mol Pharmacol (2002) 0.89
Metabolism and pharmacokinetic studies of JPH203, an L-amino acid transporter 1 (LAT1) selective compound. Drug Metab Pharmacokinet (2011) 0.88
Renal elimination of p-aminohippurate (PAH) in response to three days of biliary obstruction in the rat. The role of OAT1 and OAT3. Biochim Biophys Acta (2006) 0.88
Altered renal elimination of organic anions in rats with chronic renal failure. Biochim Biophys Acta (2005) 0.88